For decades, studies have associated coffee drinking with longer life and lower risk of chronic disease. New work from Texas A&M University’s College of Veterinary Medicine and Biomedical Sciences, published in Nutrients, offers a possible mechanism. The researchers highlight NR4A1, a nuclear receptor that helps regulate gene activity when tissues are stressed or damaged. Stephen Safe and colleagues describe NR4A1 as a nutrient sensor that reduces damage in many tissues.
The team tested multiple compounds found in coffee and found that several—especially polyhydroxy and polyphenolic compounds like caffeic acid—bind to NR4A1 and modify its activity. In laboratory models these compounds reduced cellular damage and slowed cancer cell growth in ways consistent with protection. When researchers removed NR4A1 from cells, the protective effects disappeared. Although caffeine binds the receptor, it produced little effect in the models, which may help explain similar findings for regular and decaffeinated coffee in population studies.
Safe notes the study is mechanistic and does not prove direct cause-and-effect in people. The researchers are now exploring synthetic compounds that target NR4A1 more effectively, aiming to develop treatments for cancer and other diseases.
Difficult words
- mechanism — A process that explains how something works
- regulate — To control or keep something at a certain level
- polyphenolic — A type of chemical with many phenol groups
- compound — A substance made of two or more chemicalscompounds
- receptor — A protein that receives signals in a cell
- synthetic — Made by people, not produced naturally
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Would you change your coffee drinking after reading this study? Why or why not?
- What other evidence would you want to see to be sure coffee helps people, not just cells?
- What could be the benefits and risks of making synthetic compounds that target NR4A1?
Related articles
Protein linked to chemotherapy resistance in ovarian cancer
Scientists found that some ovarian cancer cells survive cisplatin chemotherapy by stabilising their internal scaffold. They identified a protein that can be blocked in laboratory tests to restore the drug's effectiveness and may serve as a biomarker.
Study links autoantibodies to long COVID symptoms
A new study reports that some people with long COVID make autoantibodies that attack brain and nerve tissue. When researchers gave these antibodies to mice, the animals developed pain, fatigue and balance problems similar to patient symptoms.
Dementia rising in Africa as researchers seek answers
Dementia is increasing in Africa as populations age. Research and evidence in the region are limited, so scientists study genetics, new detection tools and community measures while working with traditional healers to reduce stigma.